Generic Drug Development Accelerated by Machine Learning and Automation: Complex Formulations Like Biosimilars Now Possible

Technological advancements are reshaping the generic drug industry, accelerating development processes and expanding the possibilities for new formulations. The integration of tools like machine learning and automation are streamlining research and development, which aims to decrease the time and cost of bringing generic medications to market. This process is intended to improve patient access to more affordable, high-quality drugs. Furthermore, digital technologies make it possible to create more complex generic formulations, including combination products and biosimilars. The impact of technology is being seen in several key areas. For instance, artificial intelligence and 3D printing are offering novel solutions for both manufacturers and patients. The development of more complex formulations, such as combination drugs and biosimilars, has the potential to improve treatment options and patient outcomes. The changes may also increase market competition and lower prices. Further advancements, such as personalized medicine and blockchain technology for supply chain management, are possibilities as the technology continues to evolve.

Newsflash | Powered by GeneOnline AI
Source: https://www.drugpatentwatch.com/blog/the-impact-of-technological-advances-on-generic-drug-development/ Tue, 01 Apr 2025 20:32:55 +0000

Author

Mark Chiang